Epigenetics-targeted drugs: Current paradigms and future challenges

W Dai, X Qiao, Y Fang, R Guo, P Bai, S Liu… - … and Targeted Therapy, 2024 - nature.com
Epigenetics governs a chromatin state regulatory system through five key mechanisms: DNA
modification, histone modification, RNA modification, chromatin remodeling, and non-coding …

Recent advances and challenges in uveal melanoma immunotherapy

Y Fu, W Xiao, Y Mao - Cancers, 2022 - mdpi.com
Simple Summary Uveal melanoma is the most common primary intraocular malignancy in
adults. Although it can be controlled locally, half of the patients still develop metastases. To …

The PEMDAC phase 2 study of pembrolizumab and entinostat in patients with metastatic uveal melanoma

L Ny, H Jespersen, J Karlsson, S Alsén, S Filges… - Nature …, 2021 - nature.com
Preclinical studies have suggested that epigenetic therapy could enhance immunogenicity
of cancer cells. We report the results of the PEMDAC phase 2 clinical trial (n= 29; …

Cancer immunotherapy with immunoadjuvants, nanoparticles, and checkpoint inhibitors: Recent progress and challenges in treatment and tracking response to …

MJ Gorbet, A Ranjan - Pharmacology & therapeutics, 2020 - Elsevier
Chemotherapy, surgery, and radiation are accepted as the preferred treatment modalities
against cancer, but in recent years the use of immunotherapeutic approaches has gained …

Understanding failure and improving treatment using HDAC inhibitors for prostate cancer

Z Rana, S Diermeier, M Hanif, RJ Rosengren - Biomedicines, 2020 - mdpi.com
Novel treatment regimens are required for castration-resistant prostate cancers (CRPCs)
that become unresponsive to standard treatments, such as docetaxel and enzalutamide …

Regulation of epigenetic homeostasis in uveal melanoma and retinoblastoma

P Chai, R Jia, Y Li, C Zhou, X Gu, L Yang, H Shi… - Progress in retinal and …, 2022 - Elsevier
Uveal melanoma (UM) and retinoblastoma (RB), which cause blindness and even death,
are the most frequently observed primary intraocular malignancies in adults and children …

Histone deacetylase (HDAC) inhibitors: A promising weapon to tackle therapy resistance in melanoma

K Palamaris, M Moutafi, H Gakiopoulou… - International Journal of …, 2022 - mdpi.com
Melanoma is an aggressive malignant tumor, arising more commonly on the skin, while it
can also occur on mucosal surfaces and the uveal tract of the eye. In the context of the …

Epigenetics of most aggressive solid tumors: pathways, targets and treatments

J Martinez-Useros, M Martin-Galan… - Cancers, 2021 - mdpi.com
Simple Summary The large amount of knowledge regarding epigenetic pathways has
opened a broad range of treatments that provide hope for adult patients with highly …

Genetic landscape and emerging therapies in uveal melanoma

RS Seedor, M Orloff, T Sato - Cancers, 2021 - mdpi.com
Simple Summary Uveal melanoma is the most common primary intraocular malignancy in
adults. Unfortunately, metastasis develops in up to 50% of cases and outcomes are poor for …

Molecular insights and emerging strategies for treatment of metastatic uveal melanoma

F Mallone, M Sacchetti, A Lambiase, A Moramarco - Cancers, 2020 - mdpi.com
Simple Summary Around 50% of patients with uveal melanoma (UM) still develop metastatic
disease. Despite recent advances in the diagnosis and prognosis of UM, improvements in …